HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Methylprednisolone in neonatal cardiac surgery: reduced inflammation without improved clinical outcome.

AbstractBACKGROUND:
Corticosteroids are widely used in pediatric open-heart surgery to reduce systemic inflammatory response and to mediate possible cardioprotective effects. However, the optimal dosing of corticosteroids is unknown and their administration varies considerably between different institutions.
METHODS:
Forty neonates undergoing open-heart surgery were randomized in a double-blind fashion equally into 2 groups. After the induction of anesthesia, 1 group received 30 mg/kg intravenous methylprednisolone and the other a placebo. Concentrations in plasma of interleukin 6 (IL-6), IL-8, IL-10, free methylprednisolone and total methylprednisolone were obtained for the following: (1) at anesthesia induction before the study drug was administered; (2) 30 minutes on cardiopulmonary bypass; (3) 5 minutes after protamine administration; and (4) 6 hours after weaning from cardiopulmonary bypass. Troponin T was measured at time points T1, T3, T4, and also at 6:00 on the first postoperative morning. Physiological and clinical outcome parameters were also recorded.
RESULTS:
Intravenous methylprednisolone resulted in high plasma drug concentrations that peaked at T2. Methylprednisolone significantly lowered concentrations of proinflammatory cytokines IL-6 and IL-8 and raised levels of anti-inflammatory IL-10. No significant differences in troponin T levels were detected. Blood glucose levels were significantly higher in the methylprednisolone group, and patients in this group received more often insulin therapy than controls. No significant differences were observed in other clinical or physiological outcome measurements.
CONCLUSIONS:
Intravenous 30 mg/kg methylprednisolone administered before cardiopulmonary bypass resulted in high effective plasma drug concentrations and a decreased inflammatory response. However, no cardioprotective effect or better clinical outcome was noticed.
AuthorsJuho Keski-Nisula, Eero Pesonen, Klaus T Olkkola, Kaija Peltola, Pertti J Neuvonen, Netta Tuominen, Heikki Sairanen, Sture Andersson, Pertti K Suominen
JournalThe Annals of thoracic surgery (Ann Thorac Surg) Vol. 95 Issue 6 Pg. 2126-32 (Jun 2013) ISSN: 1552-6259 [Electronic] Netherlands
PMID23602068 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Blood Glucose
  • Interleukins
  • Methylprednisolone
Topics
  • Blood Glucose (analysis, drug effects)
  • Cardiac Surgical Procedures (adverse effects, methods, mortality)
  • Cardiopulmonary Bypass (adverse effects, methods)
  • Double-Blind Method
  • Female
  • Follow-Up Studies
  • Heart Defects, Congenital (diagnosis, mortality, surgery)
  • Hospital Mortality (trends)
  • Humans
  • Infant, Newborn
  • Inflammation (prevention & control)
  • Infusions, Intravenous
  • Interleukins (blood, metabolism)
  • Male
  • Methylprednisolone (administration & dosage, adverse effects)
  • Postoperative Complications (prevention & control)
  • Preoperative Care (methods)
  • Reference Values
  • Risk Assessment
  • Sensitivity and Specificity
  • Survival Rate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: